China Shineway Pharmaceutical Group Ltd. is now the largest manufacturer of
modern Chinese medicine injections, soft capsules and granules. The Group’s
state-of-the-art facilities are located in Shijiazhuang and Lang Fang.
The Group is listed on the Main Board of the Stock Exchange of Hong Kong and
is a constituent of the Hang Seng Composite Index ranking among the top 200
public companies on the counter.
Shineway’s brand names and products are widely recognized in the PRC. The
Group offers a range of prescription and OTC modern Chinese medicines. Main
products include Shen Mai injection, Qing Kai Ling injection and Wu Fu Xin Nao
Qing soft capsule – each has sales revenue of over 150 million Renminbi
annually. Together with over 45 regularly produced modern Chinese medicines such
as Shu Xue Ning injection, Huang Qi injection, Huo Xiang Zheng Qi soft capsule,
Qing Kai Ling soft capsule and a series of granule products, Shineway’s modern
Chinese medicines are primarily focused on the treatment of illness commonly
affecting middle and old aged people and children, including cardiovascular
diseases, respiratory system sickness, cold and fever, digestive system
diseases, and medicines for anti-viral treatment. All are sold under the
As an officially certified “China Famous Trademark”, Shineway is a well known
brand and its products are popular among the Chinese people. Shineway’s
prominent brands and products have won numerous honors and awards, including
“China Five Hundred Most Valuable Brand”, “State Key New Products” and “China
Hi-Tech Products”. A number of Shineway key products are also labeled as “State
Protected Chinese medicines” and “Good Quality / Good Price” products.